0.581 s

-0.024 (-3.97%)
Range 0.576 - 0.600   (4.17%)
Open 0.584
Previous Close 0.605
Buy Price 3.800
Buy Volume 47,100
Sell Price 3.810
Sell Volume 76,900
Volume 1,521,540
Value -
Remark s
Measurement Type Value
EPS (USD) -0.536
Trailing EPS (USD) -0.364
NAV (USD) 0.61
Cash In Hand (USD) 0.702
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 0.967
Price / Cash In Hand 0.841
Issued & Paid-up Shares 116,395,000
Treasury Shares -
Market Cap (M) 29.072
Par Value (USD) n.a.
Beta - 75 Days -
R-Squared - 75 Days(%) -
Beta - 500 Days -
R-Squared - 500 Days(%) -
ISIN Code
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 23 Oct 2021 04:00.
Data powered by
View All Events

About ORAGENICS INC

Oragenics, Inc. is focused on the discovery, development and commercialization of a range of technologies associated with oral health, antibiotics and other general health benefits. The Company is developing and seeking partners or commercializing four products, including ProBiora3, LPT3-04, SMaRT Replacement Therapy and MU1140-S. The Company is focusing its efforts on growing its oral probiotic business both with its branded Evora products and through licensing and private label sales (with ProBiora3). Its SMaRT Replacement Therapy is designed to be a treatment applied to the teeth that has the potential to offer protection against dental caries, or tooth decay.

There are 3 followers

Followers
0
Followers
0
Followers
71